Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/2/2020
SIETES contiene 92913 citas

 
 
 1 a 11 de 11 
Presentar resultados
Seleccionar todas
1. Cita con resumen
McEvoy JB, Daya N, Rahman F, Hoogeveen RC, Blumenthal RS, Shah AM, Ballantyne CM, Coresh J, Selvin E. Association of isolated diastolic hypertension as defined by the 2017 ACC/AHA blood pressure guideline with incident cardiovascular outcomes. JAMA 2020;323:28 de enero. [Ref.ID 103512]
2. Cita con resumen
DeFilippis AP, Young R, Carrubba CJ, McEvoy JW, Budoff MJ, Blumenthal RS, Kronmal RA, McClelland RL, Nasir K, Blaha MJ. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med 2015;162:266-75. [Ref.ID 98824]
3.Enlace a cita original Cita con resumen
Desai CS, Martin SS, Blumenthal RS. Non-cardiovascular effects associated with statins. BMJ 2014;349:g3743. [Ref.ID 98147]
5.Tiene citas relacionadas Cita con resumen
Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA 2013;310:2061-8. [Ref.ID 96573]
6. Cita con resumen
Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, O'Leary DH, Lima J, Blumenthal RS, Nasir K. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 2011;378:684-92. [Ref.ID 91039]
7.Tiene citas relacionadas
Blumenthal RS, Michos ED. The HALTS trial - Halting atherosclerosis or halted too early?. N Engl J Med 2009;361:2178-80. [Ref.ID 87202]
8. Cita con resumen
Blumenthal RS, Michos ED. The HALTS trial — Halting atherosclerosis or halted too early?. N Engl J Med 2009;361:2178-80. [Ref.ID 87089]
9.Tiene citas relacionadas
Blumenthal RS, Kapur NK. Can a potent statin actually regress coronary atherosclerosis?. JAMA 2006;295:1583-4. [Ref.ID 76727]
10.
Gluckman TJ, Baranowski B, Ashen D, Henrikson CA, McAllister M, Braunstein JB, Blumenthal RS. A practical and evidence-based approach to cardiovascular disease risk reduction. Arch Intern Med 2004;164:1490-500. [Ref.ID 71012]
11.Tiene citas relacionadas
Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001;161:1413-9. [Ref.ID 57276]
Seleccionar todas
 
 1 a 11 de 11